Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists

Adv Pharmacol. 1998:42:443-6. doi: 10.1016/s1054-3589(08)60783-8.

Authors

K D Burris¹, S M Fausing, P B Molinoff

Affiliation

¹ CNS Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.

PMID: 9327934
DOI: 10.1016/s1054-3589(08)60783-8

No abstract available

MeSH terms

Adenylyl Cyclase Inhibitors
Brain / metabolism
Cell Line
Dopamine Agonists / pharmacology*
Dopamine Antagonists / pharmacology*
GTP-Binding Proteins / metabolism
Haloperidol / pharmacology
Humans
Kinetics
Receptors, Dopamine D2 / biosynthesis*
Receptors, Dopamine D2 / drug effects
Receptors, Dopamine D3
Recombinant Proteins / biosynthesis
Recombinant Proteins / drug effects
Salicylamides / pharmacology
Sulpiride / pharmacology
Transfection
Up-Regulation / drug effects
Virulence Factors, Bordetella / pharmacology

Substances

Adenylyl Cyclase Inhibitors
DRD3 protein, human
Dopamine Agonists
Dopamine Antagonists
Receptors, Dopamine D2
Receptors, Dopamine D3
Recombinant Proteins
Salicylamides
Virulence Factors, Bordetella
Sulpiride
GTP-Binding Proteins
Haloperidol
eticlopride